CO2023005368A2 - Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas - Google Patents

Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas

Info

Publication number
CO2023005368A2
CO2023005368A2 CONC2023/0005368A CO2023005368A CO2023005368A2 CO 2023005368 A2 CO2023005368 A2 CO 2023005368A2 CO 2023005368 A CO2023005368 A CO 2023005368A CO 2023005368 A2 CO2023005368 A2 CO 2023005368A2
Authority
CO
Colombia
Prior art keywords
controlled release
daltons
weight
filler composition
soft
Prior art date
Application number
CONC2023/0005368A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2023005368A2 publication Critical patent/CO2023005368A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CONC2023/0005368A 2020-10-16 2023-04-27 Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas CO2023005368A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
PCT/US2021/054991 WO2022081848A1 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same

Publications (1)

Publication Number Publication Date
CO2023005368A2 true CO2023005368A2 (es) 2023-05-19

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0005368A CO2023005368A2 (es) 2020-10-16 2023-04-27 Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas

Country Status (14)

Country Link
US (1) US20230372252A1 (enExample)
EP (1) EP4228608A4 (enExample)
JP (1) JP2023545494A (enExample)
KR (1) KR20230088730A (enExample)
CN (1) CN116367864A (enExample)
AR (1) AR123800A1 (enExample)
AU (2) AU2021360905B2 (enExample)
CA (1) CA3195386A1 (enExample)
CO (1) CO2023005368A2 (enExample)
IL (1) IL301692A (enExample)
MX (1) MX2023004441A (enExample)
NZ (1) NZ799086A (enExample)
TW (1) TW202228655A (enExample)
WO (1) WO2022081848A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PE20141171A1 (es) * 2011-10-06 2014-09-21 Gruenenthal Chemie Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
WO2016140933A2 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
EP3285746A1 (en) * 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
EP3856160A4 (en) * 2018-09-25 2022-07-06 SpecGx LLC ABUSE-PROOF IMMEDIATE RELEASE CAPSULE DOSAGE FORMS

Also Published As

Publication number Publication date
AU2026201700A1 (en) 2026-03-26
EP4228608A1 (en) 2023-08-23
TW202228655A (zh) 2022-08-01
AU2021360905B2 (en) 2026-01-08
AU2021360905A1 (en) 2023-06-01
KR20230088730A (ko) 2023-06-20
JP2023545494A (ja) 2023-10-30
NZ799086A (en) 2026-02-27
MX2023004441A (es) 2023-05-08
AR123800A1 (es) 2023-01-11
WO2022081848A1 (en) 2022-04-21
CN116367864A (zh) 2023-06-30
CA3195386A1 (en) 2022-04-21
AU2021360905A9 (en) 2024-10-10
IL301692A (en) 2023-05-01
EP4228608A4 (en) 2024-10-02
US20230372252A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
ES2206081T1 (es) Procedimiento para preparar composiciones farmaceuticas para uso con formulaciones de gelatina blanda.
PE20061136A1 (es) Sistema de capsulas blandas que no son de gelatina
ES2002302A6 (es) Una capsula de gelatina dura que contiene una composicion masticable
AR110986A2 (es) Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso
CO2023005368A2 (es) Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas
AR036943A1 (es) Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
MX2017012878A (es) Composiciones gomosas de multicomponentes con nucleo duro.
AR008279A1 (es) Composiciones pesticidas, un metodo para controlar pestes, un sistema de administracion para administrar dichas composiciones y un metodo para formulardichas composiciones
PE20040675A1 (es) Formulaciones de deposito de liberacion controlada
GT199900203A (es) Composiciones de celecoxib.
ES8503508A1 (es) Una forma de dosificacion unitaria farmaceutica
PE20040418A1 (es) Nuevas formulaciones farmaceuticas solidas que comprenden telmisartano y su preparacion
CO6160317A2 (es) Formas de dosificacion farmaceutica no manipulables que incluyen un analgesico opioide
AR063362A1 (es) Formas de dosificacion del clorhidrato de palonosetron que tienen estabilidad y biodisponibilidad mejorada
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
BR0307893A (pt) Formulação oftálmica com sistema de goma
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR113096A1 (es) Mezclas de composiciones biodegradables que modulan la cinética de liberación de al menos un ingrediente activo en la administración de fármacos
CO4900025A1 (es) Forma de dosificacion de gelatina blanda, de fases multiples de materiales de relleno semisolidos que contienen ingre- dientes activos
RU2015137612A (ru) Фармацевтическая дозированная лекарственная форма в виде мягкой желатиновой капсулы, содержащая модифицированную гуаровую камедь
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
HRP20200039T1 (hr) Formulacija fosfomicina za parenteralnu primjenu
PE83998A1 (es) Material de relleno para forma de dosis farmaceutica de gelatina blanda, que contiene un antiflatulento
ZA202301927B (en) Phytonadione compositions
AR041744A1 (es) Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida